| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -2.9e-05 | 1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 9.6e-05 | 1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.00025 | 1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00022 | 1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |